Scouting and assessing external assets against portfolio needs, from scientific diligence to commercial potential.
Structuring and negotiating licences, co-development deals and acquisitions.
Making partnerships work after signing: governing joint programmes and protecting value.
Deciding where to look, what to acquire and what to partner or divest, and building the value story when a biotech takes an asset to market.
Commercial due diligence, forecasting, valuation, synergy and deal modelling that underpin terms and negotiations.
Consultancies and advisers supporting buy-side and sell-side deals, partnerships and capital raising for pharma, biotech and investors.
We're not advertising roles in this area right now, but we're always speaking with clients and candidates. Get in touch for a confidential conversation.